Delivery Order SPE2DB22D1041-SPE2DB24FUDB5

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,314.56, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 3, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,329.56, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price delivery order contract. The contract was not set aside for any specific...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,266.50, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product, to support federal healthcare programs. The contract is a firm fixed-price delivery order with a completion date of January 28, 2025. It is not designated as a set-aside contract. Amerisourcebergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,241.82, is for the delivery of LIRAGLUTIDE 2-PAK 18 MG/3 ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025 and is a Firm Fixed Price agreement. This contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $8,281.33 firm fixed-price delivery order is for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product. The award has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $5,022.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML medical products. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,589.67, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a specialty medication used to treat diabetes. The contract has an ultimate completion date of March 17, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,585.83, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price type and has an ultimate completion date of March 3, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,117.95 firm fixed-price delivery order is for the supply of Liraglutide 3-Pak 18 mg/3 ml 3ml medication. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml prescriptions. The contract has a ceiling value of $3,255.63 and an ultimate completion date of August 19, 2024. The contract was awarded on August 16, 2024 as a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. AmerisourceBergen, through...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUDB5
    Delivery Order

This federal contract award, valued at $5,933.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a prescription drug product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various government agencies, including the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, to supply a wide range of pharmaceutical and medical products to support military treatment facilities, veterans' hospitals, and other federal healthcare providers.

Generated 11/7/24, 9:42 AM